Atlas Trials

ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy

Clinical trial NCT03122262 · COMPLETED

Trial details

NCT number
NCT03122262
Sponsor
Professor Francois Venter
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HIV-1 Infection
Start date
2017-01-16
Primary completion
2022-04-30
Enrollment
1110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.